IP Library Granted Patent US 7,064,201
Granted Patent B2
US 7,064,201 · App. 10/632,531 · Granted Jun 20, 2006

Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

Assignee: Nereus Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,064,201
App. No.
10/632,531
Granted
Jun 20, 2006
Kind
B2
Abstract

Compounds represented by the following structure (I) are disclosed: as are methods for making such compounds, wherein said methods comprise reacting a diacyldiketopiperazine with a first aldehyde to produce an intermediate compound; and reacting the intermediate compound with a second aldehyde to produce the class of compounds with the generic structure, where the first aldehyde and the second aldehydes are selected from the group consisting of an oxazolecarboxaldeyhyde, imidazolecarboxaldehyde, a benzaldehyde, imidazolecarboxaldehyde derivatives, and benzaldehyde derivatives, thereby forming the above compound wherein R 1 , R 1 ′, R 1 ″, R 2 , R 3 , R 4 , R 5 , and R 6 , X 1 and X 2 , Y, Z, Z 1 , Z 2 , Z 3 , and Z 4 may each be separately defined in a manner consistent with the accompanying description. Compositions and methods for treating cancer and fungal infection are also disclosed.

Claims (21)

1. A compound having the structure of Formula (I):

wherein

R 1 , and R 6 , are each separately selected from the group consisting of a hydrogen atom, a halogen atom, hydroxy, and cyano, or seperately from the group consisting of saturated C 1 –C 24 alkyl, unsaturated C 1 –C 24 alkenyl, cycloalkyl, cycloalkenyl, alkoxy, cycloalkoxy, aryl, heteroaryl, amino, nitro, azido, phenyl, carboxy, —CO—O—R 7 , alkylthio, halogenated alkyl including polyhalogenated alkyl, halogenated carbonyl, and carbonyl —CCO—R 7 , each optionally substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, aclyamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO—alkyl, —SO—aryl, —SO—heteroaryl, —SO 2 —alkyl, —SO 2 —aryl, and —SO 2 —heteroaryl;

R 7 is selected from a hydrogen atom or, a halogen atom, or selected from the group consisting of saturated C 1 –C 24 alkyl, unsaturated C 1 –C 24 alkenyl, cycloalkyl, cycloalkenyl, alkoxy, cycloalkoxy, aryl, heteroaryl, amino, nitro, azido, and phenyl groups, each optionally substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, aclyamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO—alkyl, —SO—aryl, —SO—heteroaryl, —SO 2 —alkyl, —SO 2 —aryl, and —SO 2 —heteroaryl;

R 4 is a tert-butyl group;

R 1 ′ and R 1 ″ are each independently selected from the group consisting of a hydrogen atom, a halogen atom, hydroxy, and cyano, or indepently selected from the group consisting of saturated C 1 –C 24 alkyl, unsaturated C 1 –C 24 alkenyl, cycloalkyl, cycloalkenyl, alkoxy, cycloalkoxy, aryl, heteroaryl, amino, nitro, azido, phenyl, carboxy, —CO—O—R 7 , alkylthio, halogenated alkyl including polyhalogenated alkyl, halogenated carbonyl, and carbonyl —CCO—R 7 , each optionally substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, aclyamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO—alkyl, —SO—aryl, —SO—heteroaryl, —SO 2 —alkyl, —SO 2 —aryl, and —SO 2 —heteroaryl;

R, R 1 ′ and R 1 ″ are either covalently bound to one another or are not covalently bound to one another;

R 2 , R 3 , and R 5 are each separately selected from the group consisting of a hydrogen atom, or a halogen atom, or seperately selected from the group consisting of saturated C 1 –C 12 alkyl, unsaturated C 1 –C 12 alkenyl, acyl, cycloalkyl, alkoxy, cycloalkoxy, aryl, heteroaryl, amino, nitro, and sulfonyl and substituted sulfonyl groups, each optionally substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, aclyamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO—alkyl, —SO—aryl, —SO—heteroaryl, —SO 2 —alkyl, —SO 2 —aryl, and —SO 2 —heteroaryl;

X 1 and X 2 are separately selected from the group consisting of an oxygen atom, a nitrogen atom, and a sulfur atom, each either unsubstituted or substituted with a R 5 group, as defined above;

Y is selected from the group consisting of a nitrogen atom, a nitrogen atom substituted with R 5 , an oxygen atom, a sulfur atom, a oxidized sulfur atom, a methylene group and a substituted methylene group substituted with one or more R 5 ;

n is an integer equal to zero, one or two;

Z, for each separate n, if non-zero, and Z 1 , Z 2 , Z 3 and Z 4 are each separately selected from a carbon atom, a sulfur atom, a nitrogen atom or an oxygen atom; and

the dashed bonds may be either single or double bonds.

2. The compound of claim 1 , wherein each of R 2 , R 3 , R 5 and R 6 is a hydrogen atom.

3. The compound of claim 1 , wherein each of X 1 and X 2 is an oxygen atom.

4. The compound of to claim 1 , wherein R 1 is a phenyl group substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, aclyamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO—alkyl, —SO—aryl, —SO—heteroaryl, —SO 2 —alkyl, —SO 2 —aryl, and —SO 2 —heteroaryl.

5. The compound of claim 4 , wherein the substituted phenyl group is methoxybenzene.

6. The compound according to claim 1 , wherein n is equal to zero or one.

7. The compound according to claim 1 , wherein n is equal to one.

8. The compound according to claim 1 , wherein n is equal to one and Z, Z 1 , Z 2 , Z 3 and Z 4 are each a carbon atom.

9. The compound of claim 1 , wherein said compound is selected from the group consisting of: KPU-2, KPU-11, KPU-35, KPU-66, KPU-80, KPU-81, and KPU-90.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2014
From: DALIAN WANCHUN BIOTECHNOLOGY CO. LTD.
To: BEYONDSPRING PHARMACEUTICALS, INC.
Reel/Frame 033519/0194 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2013
From: DALIAN WANCHUN BIOTECHNOLOGY CO. LTD.
To: BEYONDSPRING PHARMACEUTICALS, INC.
Reel/Frame 030723/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2013
From: NEREUS PHARMACEUTICALS, INC.
To: DALIAN WANCHUN BIOTECHNOLOGY CO. LTD.
Reel/Frame 030715/0457 →
SECURITY AGREEMENT Recorded May 21, 2009
From: NEREUS PHARMACEUTICALS, INC.
To: HBM BIOVENTURES (CAYMAN) LTD.; HBM BIOCAPITAL (EUR) L.P.; HBM BIOCAPITAL (USD) L.P.; PRIVATE LIFE BIOMED AG; ALSTERTOR PRIVATE LIFE GMBH & CO. KG; ADVENT HEALTHCARE AND LIFE SCIENCES III LIMITED PARTNERSHIP; ADVENT HEALTHCARE AND LIFE SCIENCES III-A LIMITED PARTNERSHIP; ADVENT PARTNERS HLS III LIMITED PARTNERSHIP; PACIFIC VENTURE GROUP II, L.P.; PVG ASSOCIATES II, L.P.; FORWARD VENTURES IV, L.P.; FORWARD VENTURES IV B, L.P.; GIMV N.V.; GIMV ADVIESBEHEER LIFE SCIENCES N.V.; LOTUS BIOSCIENCE INVESTMENT HOLDS LTD; NOVARTIS BIOVENTURE FUND / NOVARTIS INTERNATIONAL AIG; HENSLER, MARY; JACOBS, ROBERT; WS INVESTMENT COMPANY; GENAVENT PARTNERS LP; ASTELLAS VENTURE FUND I LP; ROCHE FINANCE LTD; ALTA CALIFORNIA PARTNERS II, L.P.; ALTA EMBARCADERO PARTNERS II, LLC; ALTA CALIFORNIA PARTNERS II, L.P. - NEW POOL
Reel/Frame 022719/0115 →
SECURITY AGREEMENT Recorded Aug 11, 2004
From: NEREUS PHARMACEUTICALS, INC.
To: ALTA CALIFORNIA PARTNERS II, L.P.; ALTA EMBARCADERO PARTNERS II, LLC; FORWARD VENTURES IV, L.P.; FORWARD VENTURES IV B, L.P.; FORWARD VENTURES III, L.P.; FORWARD VENTURES III INSTITUTIONAL PARTNERS, L.P.; GIMV N.V.; GIMV ADVIESBEHEEER LIFE SCIENCES N.V.; PACIFIC VENTURE GROUP II, L.P.; PVG ASSOCIATES II, L.P.
Reel/Frame 015017/0484 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2004
From: HAYASHI, YOSHIO; PALLADINO JR., MICHAEL A.; GRODBERG, JENNIFER
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 014303/0328 →
Continuity (4)
Provisional Application 6045006300 · Feb 23, 2003
Provisional Application 6041112800 · Sep 16, 2002
Provisional Application 6040107400 · Aug 2, 2002
Related Publication 20050090667A1 · Apr 28, 2005